CARBAMAZEPINE - ANVISA Registration 80146501916

Access comprehensive regulatory information for CARBAMAZEPINE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80146501916 and manufactured by MICROGENICS CORPORATION. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until Jun 16, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80146501916
2 Related Devices
Registration Details
ANVISA Registration Number: 80146501916
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

CARBAMAZEPINE
Risk Class III

Registration Details

80146501916

25351714537201414

56998701000116

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Feb 18, 2015

16/06/2035

09/18/2025 19:00:01

CARBAMAZEPINE
Risk Class III

Registration Details

80146501916

25351714537201414

56998701000116

Company Information

Dates and Status

Feb 18, 2015

16/06/2035

09/18/2025 19:00:01